A
Armando Santoro
Researcher at Humanitas University
Publications - 961
Citations - 56759
Armando Santoro is an academic researcher from Humanitas University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 93, co-authored 847 publications receiving 48505 citations. Previous affiliations of Armando Santoro include Aix-Marseille University & University of Milan.
Papers
More filters
Journal ArticleDOI
Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study
Lucia Morello,Sara Rattotti,Laura Giordano,Mats Jerkeman,Tom van Meerten,Katarzyna Krawczyk,Filipa Moita,Dario Marino,Simone Ferrero,Michal Szymczyk,Igor Aurer,Tarec Christoffer El-Galaly,Alice Di Rocco,Carlo Visco,Giuseppe Carli,Irene Defrancesco,Carmelo Carlo-Stella,Martin Dreyling,Armando Santoro,Luca Arcaini +19 more
TL;DR: This research presents a novel probabilistic procedure called “spot-spot analysis” that allows for real-time analysis of the response of the immune system to foreign substance abuse.
Journal ArticleDOI
Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin’s lymphoma. Assessment of risk of toxicity and secondary cancer induction
Marta Scorsetti,Luca Cozzi,Pierina Navarria,Antonella Fogliata,Alexia Rossi,Davide Franceschini,Fiorenza De Rose,Ciro Franzese,Carmelo Carlo-Stella,Armando Santoro +9 more
TL;DR: In relation to young female patients with advanced supradiaphragmatic HL, IMPT can in general offer improved dose-volume sparing of organs at risk leading to an anticipated lower risk of early or late treatment related toxicities.
Journal ArticleDOI
Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial.
Hedy L. Kindler,Silvia Novello,Alessandra Bearz,Giovanni Luca Ceresoli,Joachim G.J.V. Aerts,James Spicer,Paul J. Taylor,Kristiaan Nackaerts,Alastair Greystoke,Ross Jennens,Luana Calabrò,Jacobus A. Burgers,Armando Santoro,Susana Cedres,Piotr Serwatowski,Santiago Ponce,Jan P. van Meerbeeck,Anna K. Nowak,George R. Blumenschein,Jonathan Siegel,Linda E Kasten,Karl Köchert,Annette O Walter,Barrett H. Childs,Cem Elbi,Raffit Hassan,Dean A. Fennell +26 more
TL;DR: In this paper , the authors compared the antibody-drug conjugate anetumab ravtansine versus vinorelbine in patients with unresectable locally advanced or metastatic disease overexpressing mesothelin.
Journal ArticleDOI
Neutrophil and lymphocyte blood count as potential predictive indicators of nivolumab efficacy in metastatic non-small-cell lung cancer
TL;DR: It is suggested that NLR value at first tumor assessment or NLR trend could be used as prognostic indicators during nivolumab treatment in metastatic non-small-cell lung cancer.
Journal ArticleDOI
Intra-arterial induction chemotherapy for soft tissue sarcomas.
A. Azzarelli,Vittorio Quagliuolo,S. Fissi,Paolo G. Casali,A. Garbuglia,P. Bignami,Armando Santoro,S. Andreola,L. Gennari +8 more
TL;DR: The major practical effect of this induction chemotherapy is the selection of patients with better prognosis and the possibility of perform, in some cases, easier limb salvage procedures, which seems to provide little better but not yet significant results.